PMID: 9436281Jan 1, 1997Paper

Population-based prostate cancer trends in the United States: patterns of change in the era of prostate-specific antigen

World Journal of Urology
R A Stephenson, J L Stanford

Abstract

We reviewed prostate cancer trends prior to and during the prostate-specific antigen (PSA) era using data reported from population-based tumor registries in the United States. On the basis of a summary of reports from several population-based tumor registries, prostate cancer incidence rose abruptly during the PSA era, peaked in 1992, and then fell just as abruptly. Prostate cancer incidence in the United States now appears to be approaching levels seen in the pre-PSA era. The flux in prostate cancer incidence (in both magnitude and slope) during the years 1988-1995 is without precedent in oncology. As expected, an age and stage migration toward early age and early stage has been observed. Unexpectedly, grade has shifted heavily toward moderate differentiation, whereas rates of poorly and well-differentiated disease have remained relatively stable. Local treatment rates, particularly radical prostatectomy rates, have risen substantially. Mortality rates appear to have leveled or declined slightly since 1991 after years of steady rise.

References

Apr 22, 1992·JAMA : the Journal of the American Medical Association·H B CarterP C Walsh
Jan 25, 1995·JAMA : the Journal of the American Medical Association·P H GannM J Stampfer
Feb 15, 1995·JAMA : the Journal of the American Medical Association·A L PotoskyB S Kramer
Aug 25, 1993·JAMA : the Journal of the American Medical Association·W J CatalonaJ W Basler
Jan 1, 1996·CA: a Cancer Journal for Clinicians·S L ParkerP A Wingo
Nov 20, 1996·Journal of the National Cancer Institute·R M MerrillE J Feuer

❮ Previous
Next ❯

Citations

Feb 19, 2004·Urologic Oncology·O Kenneth Macdonald, Steven E Schild
Dec 4, 1998·Urology·R Kirby
Jul 23, 2003·International Journal of Radiation Oncology, Biology, Physics·Derek B ChismAlan Pollack
Apr 28, 2001·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·G Sandblom, E Varenhorst
Feb 22, 2012·Asian Journal of Andrology·Takumi ShiraishiPrakash Kulkarni
Feb 21, 2004·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Wael A Sakr
May 17, 2007·Prostate Cancer and Prostatic Diseases·A B JaniP A S Johnstone
Oct 11, 2008·American Journal of Clinical Oncology·Ashesh B JaniOtis W Brawley
Apr 20, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tanya B DorffL Michael Glode
Jan 21, 2006·AJR. American Journal of Roentgenology·Tamar SellaHedvig Hricak
Jan 3, 2001·AJR. American Journal of Roentgenology·J R ThornburyJ C Weinreb
Apr 29, 2005·Radiology·Daniel T SchmidThomas F Hany
Mar 16, 2001·Expert Opinion on Pharmacotherapy·D K Ornstein, R S Pruthi
Apr 15, 2014·The Urologic Clinics of North America·Richard J Bryant, Hans Lilja
Feb 1, 2011·International Journal of Radiation Oncology, Biology, Physics·Abraham S AlexanderCharles M Ludgate
Aug 14, 2010·Primary Care·Bob DjavanHerbert Lepor
Feb 24, 2009·The Journal of Urology·Edan Y ShapiroLouis Potters
Mar 26, 2004·Clinical Prostate Cancer·Judd W Moul
Mar 30, 2004·Clinical Prostate Cancer·Judd W MoulShiv Srivastava
May 17, 2005·BJU International·Yan Kit FongBob Djavan
Mar 11, 2004·BJU International·M H WinklerD A Gillatt
Apr 22, 2011·Journal of Magnetic Resonance Imaging : JMRI·Shilpa R KumbhaniAntonio C Westphalen
Jan 22, 2005·European Urology·Khurshid R GhaniS Alan McNeill

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.